Analysts expect AC Immune SA to report revenue of 2.26 M for Q4 26, against a range of 2.05 M to 2.47 M. The most recent reported quarter, Q3 26, came in at 3.99 M , in line with the 342,172.31 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 30.07 M | 1.26 M | 1.12 M | 1.65 M | 954,040.00 | 428,880.00 | 1.40 M | 18.70 M | 3.99 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 9.15 M | 925,731.82 | 378,202.96 | 2.56 M | 1.05 M | 1.49 M | 340,279.27 | 37.54 M | 356,274.60 | 2.47 M | 0.00 | 0.00 | 5.14 M | 13.02 M | 39.36 M | 38.43 M | 28.73 M | |||||||||
| Low Estimate | 8.61 M | 807,945.76 | 337,840.32 | 2.15 M | 982,868.16 | 1.26 M | 294,238.65 | 33.58 M | 328,070.02 | 2.05 M | 0.00 | 0.00 | 4.50 M | 11.39 M | 34.91 M | 33.32 M | 24.57 M | |||||||||
| Consensus Estimate | 8.88 M | 866,838.79 | 358,021.64 | 2.35 M | 1.02 M | 1.38 M | 317,258.96 | 35.56 M | 342,172.31 | 2.26 M | 0.00 | 0.00 | 4.82 M | 12.21 M | 37.14 M | 35.87 M | 26.65 M |
Analysts expect AC Immune SA to report earnings per share of -0.19 for Q3 26, against a range of -0.21 to -0.17. The most recent reported quarter, Q2 26, came in at 0.02, a 81.8% miss against the 0.11 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.06 | -0.18 | -0.21 | -0.26 | -0.16 | -0.18 | -0.19 | 0.02 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.14 | -0.20 | -0.20 | -0.21 | -0.20 | -0.19 | -0.18 | 0.12 | -0.17 | -0.16 | -0.03 | 0.23 | 0.06 | 0.01 | 0.02 | 0.29 | ||||||||||
| Low Estimate | -0.16 | -0.22 | -0.24 | -0.25 | -0.22 | -0.21 | -0.20 | 0.10 | -0.21 | -0.20 | -0.03 | 0.21 | 0.06 | 0.01 | 0.02 | 0.25 | ||||||||||
| Consensus Estimate | -0.15 | -0.21 | -0.22 | -0.23 | -0.21 | -0.20 | -0.19 | 0.11 | -0.19 | -0.18 | -0.03 | 0.22 | 0.06 | 0.01 | 0.02 | 0.27 |
Pull Wall Street consensus for AC Immune SA (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ACIU&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ACIU", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ACIU&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();